Addex Therapeutics Ltd Sponsored ADR (ADXN) Stock Price

5.6951 ▼ -0.2449 (-4.12%)
Open: 6.16 Vol: 1.3K Day's range: 5.6951 - 6.16 Jul 17, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ADXN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 6.27▼ 6.27▼ 6.27▼ 5.87▼ 6.02▼
MA10 6.45▼ 6.51▼ 6.51▼ 5.90▼ 6.27▼
MA20 6.68▼ 6.76▼ 6.72▼ 5.97▼ 6.45▼
MA50 6.77▼ 6.77▼ 7.03▼ 6.35▼ 7.61▼
MA100 7.52▼ 7.94▼ 8.07▼ 6.55▼ 8.09▼
MA200 8.21▼ 7.94▼ 7.91▼ 7.46▼ 33.04▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.094▼ -0.093▼ -0.072▼ 0.018▲ -0.017▼
RSI 35.245▼ 36.821▼ 38.034▼ 43.297▼ 40.014▼
STOCH 24.074     23.938     23.454     40.154     23.716    
WILL %R -100.000▼ -100.000▼ -100.000▼ -97.712▼ -95.724▼
CCI -177.883▼ -185.154▼ -186.771▼ -41.686     -115.981▼
Latest Filters Detected On ADXN
MA $ADXN Price Crossed Below MA(13) Set Alert
▲ GAP $ADXN Open Gap Up %3 Set Alert
▲ GAP $ADXN Open Gap Up %2 Set Alert
CDL $ADXN Engulfing Candlestick Pattern Detected Set Alert
CDL $ADXN Marubozu Candlestick Pattern Detected Set Alert
Addex Therapeutics Ltd Sponsored ADR News
Addex Therapeutics: Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
Wednesday, July 08, 2026 12:10 AM
Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...
Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
Thursday, June 25, 2026 01:59 PM
Despite financial hurdles, Addex Therapeutics Ltd (ADXN) makes significant strides in drug development and strategic positioning.
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
Sunday, June 21, 2026 10:00 PM
Geneva, Switzerland, June 22, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
ADXN historical stock data
date open high low close volume
17/07/26 6.16 6.16 5.6951 5.6951 1,298
16/07/26 5.94 5.94 5.94 5.94 250
15/07/26 5.92 6.185 5.92 6.185 2,558
14/07/26 6.09 6.12 5.7901 5.80 5,989
13/07/26 5.84 6.31 5.68 5.71 6,306
10/07/26 6.34 6.34 6.34 6.34 323
09/07/26 5.89 5.89 5.89 5.89 0
08/07/26 5.89 5.89 5.89 5.89 386
07/07/26 5.79 5.79 5.79 5.79 0
06/07/26 5.79 5.79 5.79 5.79 0
Quote Details
52wk Low:5.41
52wk High:12.05
Vol:1.3K
Avg Vol(3m):57.8K
1Y Chng:-30.04%
1M Chng:-15.00%
Add to Watch List
More Information
Index US Composite
Market Cap. 7.52M